Baxter Healthcare Corp.

FDA Regulatory Profile

Baxter Healthcare Corp. has 583 FDA recalls (110 Class I), 124 inspections, 570 510(k) clearances and 9 compliance actions on record.

What these totals cover: FDA records filed under the name "Baxter Healthcare Corp." and its spelling variants "Baxter Healthcare", "Baxter Healthcare Corporation", "Baxter Corporation", "Baxter". Records filed under related names are not included; see Related names.

Latest recall
Z-0151-2027 · Class II · Sep 14, 2026
Latest inspection
Sep 23, 2026 · VAI
Latest 510(k)
Dec 16, 2025

Reviewing Baxter Healthcare Corp. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Baxter Healthcare Corp. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls583 (110 Class I)Nov 8, 2026File dated Nov 3, 2026Current
510(k) clearances570Nov 8, 2026File dated Nov 2, 2026Current
Inspections124Nov 13, 2026Newest record Nov 5, 2026Current
Compliance actions9Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Baxter Healthcare Corp.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Baxter Healthcare Corp.: FDA inspections per year 2017: 8 inspections820172018: 6 inspections620182019: 2 inspections220192020: 1 inspections120202021: 3 inspections320212022: 3 inspections320222023: 6 inspections620232024: 4 inspections420242025: 5 inspections520252026: 3 inspections32026
YearInspectionsOAIWarning lettersRecall recordsClass I
2026311379
20255106513
20244208724
2023610469
2022300749
2021300184
2020100344
2019200180
2018600370
2017800172

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Recent recalls

583 recall records from Jul 31, 2009 to Sep 14, 2026. Showing the 20 most recent. View all 583 recall records

NumberClassProductDate
Z-0151-2027Class IILikorall Overhead Lifts Product Code: 3121001 Product Description: LIKORALL 200 Product Code…Sep 14, 2026
Z-3264-2026Class IIPRO+ 40" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system…Aug 18, 2026
Z-3263-2026Class IIPRO+ 36" MRS SURFACE, mattress with Advanced Microclimate Technology (AMT) uses a non-powered system…Aug 18, 2026
Z-3262-2026Class IIPRO+ MRS SURFACE FOR VERSACARE, mattress with Advanced Microclimate Technology (AMT) uses a…Aug 18, 2026
D-0850-2026Class IDextrose Injection, USP, 70 %, 2000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL…Aug 17, 2026
D-0849-2026Class I0.9% Sodium Chloride Injection USP 500 mL, VIAFLEX Plastic Containers, with 24 units per case…Aug 17, 2026
Z-3066-2026Class IIBaxter Novum IQ Syringe Pump, Loaner, Model Number 40800BAXUSLAug 11, 2026
Z-3065-2026Class IIBaxter Novum IQ Syringe Pump, Model Number 40800BAXUSAug 11, 2026
D-0812-2026Class IIPantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion…Aug 6, 2026
D-0819-2026Class IIVasopressin, in 0.9% Sodium Chloride Injection, 40 units per 100 mL (0.4 units/mL), 100mL…Aug 6, 2026
D-0806-2026Class IIMYXREDLIN, Insulin Human in 0.9% Sodium Chloride Injection, 100 units/100 mL (1 unit/mL), Rx only…Aug 6, 2026
D-0813-2026Class IICARDENE IV (Nicardipine Hydrochloride) in 0.83% Sodium Chloride Injection, 40 mg in 200 mL (0.2…Aug 6, 2026
D-0817-2026Class IIClindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose…Aug 6, 2026
D-0820-2026Class IIVancomycin Injection, USP, in 0.9% Sodium Chloride, 1g per 200 mL (5 mg/mL) in GALAXY Single-Dose…Aug 6, 2026
D-0811-2026Class IIVasopressin, in 0.9% Sodium Chloride Injection, 20 units per 100 mL (0.2 units/mL), 100mL…Aug 6, 2026
D-0818-2026Class IIClindamycin Injection USP in 5% Dextrose, 900 mg/50 mL (18 mg/mL), in GALAXY 50 mL Single Dose…Aug 6, 2026
D-0816-2026Class IIClindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL…Aug 6, 2026
D-0808-2026Class IIClindamycin Injection USP in 5% Dextrose, 600 mg per 50 mL (12 mg/mL) in GALAXY 50 mL Single Dose…Aug 6, 2026
D-0809-2026Class IIFamotidine Injection in Sodium Chloride Injection, 20 mg, 50 mL in GALAXY Single Dose Container, Rx…Aug 6, 2026
D-0807-2026Class IIDaptomycin, in 0.9% Sodium Chloride Injection, 500 mg per 50 mL (10 mg/mL), 500 mg total, in 50 mL…Aug 6, 2026

Recent FDA inspections

124 inspections from Feb 13, 2009 to Sep 23, 2026. Showing the 20 most recent. View all 124 inspections

DateSiteProductClassificationFEI
Sep 23, 2026Aibonito, PRDrugsVoluntary Action Indicated (VAI)2649614
Jun 3, 2026Haina, Dominican Republic (The)DevicesNo Action Indicated (NAI)3002806443
Apr 2, 2026Round Lake, ILDrugsOfficial Action Indicated (OAI)1416980
Nov 25, 2025Round Lake, ILBiologicsVoluntary Action Indicated (VAI)1416980
Sep 29, 2025Cleveland, MSDrugsOfficial Action Indicated (OAI)1019003
Apr 4, 2025Medina, NYDevicesVoluntary Action Indicated (VAI)1314492
Mar 26, 2025Guayama, PRDrugsVoluntary Action Indicated (VAI)2650090
Jan 31, 2025Alliston, CanadaDrugsVoluntary Action Indicated (VAI)3002891260
Aug 1, 2024Round Lake, ILDrugsOfficial Action Indicated (OAI)1416980
Jul 19, 2024Jayuya, PRDrugsVoluntary Action Indicated (VAI)2618677
Feb 9, 2024Marion, NCDrugsOfficial Action Indicated (OAI)1025114
Feb 6, 2024Deerfield, ILDrugsNo Action Indicated (NAI)1417572
Nov 29, 2023Aibonito, PRDrugsVoluntary Action Indicated (VAI)2649614
Nov 17, 2023Lessines, BelgiumDrugsVoluntary Action Indicated (VAI)3005468265
Nov 15, 2023Aibonito, PRDrugsNo Action Indicated (NAI)2649614
Oct 31, 2023Marion, NCBiologicsOfficial Action Indicated (OAI)1025114
Aug 18, 2023Round Lake, ILDevicesVoluntary Action Indicated (VAI)1416980
Jul 14, 2023Cleveland, MSDevicesNo Action Indicated (NAI)1019003
Jul 5, 2022Old Toongabbie, AustraliaDrugsVoluntary Action Indicated (VAI)1000440083
Jun 9, 2022Deerfield, ILDevicesVoluntary Action Indicated (VAI)1417572
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 9 compliance actions under Baxter Healthcare Corp.: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Sep 29, 2026.

Individual actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

19 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 2649614Aibonito, PR8Sep 23, 2026
FEI 3002806443Haina, Dominican Republic (The)2Jun 3, 2026
FEI 1416980Round Lake, IL19Apr 2, 2026
FEI 1019003Cleveland, MS13Sep 29, 2025
FEI 1314492Medina, NY7Apr 4, 2025
FEI 2650090Guayama, PR9Mar 26, 2025
FEI 3002891260Alliston, Canada4Jan 31, 2025
FEI 2618677Jayuya, PR13Jul 19, 2024
FEI 1025114Marion, NC11Feb 9, 2024
FEI 1417572Deerfield, IL11Feb 6, 2024
FEI 3005468265Lessines, Belgium2Nov 17, 2023
FEI 1000440083Old Toongabbie, Australia1Jul 5, 2022
FEI 1036337Largo, FL4Aug 23, 2017
FEI 2025695Irvine, CA3Mar 3, 2017
FEI 3002806471Swinford, Ireland3Jan 26, 2017
FEI 3006472186Mountain View, CA4Nov 29, 2016
FEI 3007319130Vancouver, WA4Jan 7, 2016
FEI 2937398Hayward, CA4May 5, 2015
FEI 3005185784Buffalo Grove, IL2Feb 23, 2012

Recent 510(k) clearances

570 510(k) clearances from Jan 6, 1977 to Dec 16, 2025. Showing the 20 most recent. View all 570 510(k) clearances

K-NumberDeviceDate
K251745Welch Allyn FlexiPort Blood Pressure Cuffs (FlexiPort Blood Pressure Cuffs)Dec 16, 2025
K251636Spectrum IQ Infusion System with Dose IQ Safety Software (3570009)Jul 28, 2025
K251640SIGMA Spectrum Infusion Pump with Master Drug LibraryJul 28, 2025
K243529Solution Administration SetsMar 14, 2025
K242339Intravascular Extension Sets and AccessoriesFeb 28, 2025
K242390Novum IQ Syringe Pump (40800BAXUS)Sep 5, 2024
K241564Actifuse ABX; Actifuse MIS; Actifuse Shape; ALTAPORE; ALTAPORE SHAPE; ALTAPORE MISAug 2, 2024
K230665Dose IQ Safety SoftwareMar 29, 2024
K211122Novum IQ Large Volume PumpMar 29, 2024
K231849MiniCap Extended Life PD Transfer Set with Twist Clamp - Code 5C4482A; MiniCap Extended Life PD…Mar 12, 2024
K232467CleanCart A, CleanCart C, AK 98 Hemodialysis MachineSep 14, 2023
K230022Baxter SIGMA Spectrum Infusion Pump with Master Drug LibraryMar 31, 2023
K230041Spectrum IQ Infusion System with Dose IQ Safety SoftwareMar 31, 2023
K223175lntravascular Administration Sets with Stopcock and ManifoldMar 10, 2023
K220558Blood Administration SetsNov 17, 2022
K212262PCA Syringe SetsOct 3, 2022
K222048Spectrum IQ Infusion System with Dose IQ Safety SoftwareSep 6, 2022
K211124Dose IQ Safety SoftwareAug 30, 2022
K211125Novum IQ Syringe PumpAug 30, 2022
K220417Spectrum IQ Infusion System with Dose IQ Safety SoftwareApr 29, 2022

Need more than this page shows? Ask about Baxter Healthcare Corp. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.